Results 21 to 30 of about 19,210 (233)

Central Serous Chorioretinopathy [PDF]

Ophthalmologica, 2014
The pathogenesis of central serous chorioretinopathy (CSC) is still not fully understood. The involvement of corticosteroids is undisputed, although their exact role has not been clarified; other parts of the underlying mechanism of CSC have been mainly elucidated by imaging techniques such as fluorescein and indocyanine green angiography.
Liegl, Raffael, Ulbig, Michael W.
openaire   +4 more sources

Central Serous Chorioretinopathy – an Overview [PDF]

Klinische Monatsblätter für Augenheilkunde, 2021
AbstractCentral serous chorioretinopathy (CSCR) is characterised by retinal serous detachment usually localised in the macular region. CSCR predominantly affects men between 30 and 50 years of age. Traditional classification differentiates between acute (duration shorter than 4 to 6 months) and chronic disease (duration longer than 4 to 6 months).
Berger, L., Bühler, V., Yzer, S.
openaire   +2 more sources

Central serous chorioretinopathy: A review

Clinical and Experimental Ophthalmology, 2023
Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy associated with fluid leakage. The pathogenesis is not yet completely understood, but changes in the choroid, sclera and RPE have been described associated with ...
A. Fung, Yi Yang, A. Kam
semanticscholar   +1 more source

Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies

Eye and Vision, 2023
Central serous chorioretinopathy (CSCR), first described by Albrecht von Graefe in 1866, is characterized by focal serous detachment of the neural retina and/or retinal pigment epithelium (RPE) in the posterior pole.
Xinyuan Zhang, C. Lim, J. Chhablani, Y. M. Wong   +3 more
semanticscholar   +1 more source

Macular pigment optical density in central serous chorioretinopathy

Therapeutic Advances in Ophthalmology, 2021
Purpose: The aim of our study was to evaluate the macular pigment optical density in patients with acute and chronic central serous chorioretinopathy and to describe the association between central retinal thickness and choroidal thickness with the ...
Burcu Polat Gultekin, Esra Sahli
doaj   +1 more source

Pathomechanisms in central serous chorioretinopathy: A recent update

International Journal of Retina and Vitreous, 2023
Background Central serous chorioretinopathy (CSCR) is a potentially blinding choroidal disease. Despite decades of research, the pathological mechanisms of CSCR are still poorly understood.
Arman Zarnegar, J. Ong, Tejaswini Matsyaraja, S. Arora, J. Chhablani   +4 more
semanticscholar   +1 more source

Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.

Progress in retinal and eye research, 2021
In central serous chorioretinopathy (CSC), the macula is detached because of fluid leakage at the level of the retinal pigment epithelium. The fluid appears to originate from choroidal vascular hyperpermeability, but the etiology for the fluid is ...
R. Spaide, Chui Ming Gemmy Cheung, H. Matsumoto, S. Kishi, C. Boon, E. V. van Dijk, M. Mauget-Faysse, F. Behar-Cohen, M. Hartnett, S. Sivaprasad, T. Iida, David M. Brown, J. Chhablani, P. Maloca   +13 more
semanticscholar   +1 more source

Choroidal vascular changes on ultra-widefield indocyanine green angiography in central serous chorioretinopathy: CERTAIN study report 1.

Ophthalmology Retina, 2023
PURPOSE Choroidal venous overload was recently suggested to be a pathogenetic factor in central serous chorioretinopathy (CSC). Manifestations of venous overload on ultra-widefield indocyanine green angiography (UWF ICGA) include asymmetric arterial ...
Laurenz J. B. Pauleikhoff, R. Diederen, J. Chang-Wolf, Annette C. Moll, R. Schlingemann, E. V. van Dijk, C. Boon   +6 more
semanticscholar   +1 more source

Comparing interventions for chronic central serous chorioretinopathy: A network meta-analysis.

Survey of ophthalmology, 2023
We compare efficacy of treatments for chronic central serous chorioretinopathy (CSCR) > 3 months. Four treatment classes were considered: photodynamic therapy (PDT), subthreshold laser therapies (SLT), mineralocorticoid receptor antagonists (MRA) and ...
E. You, M. Hébert, T. Jin, S. Bourgault, M. Caissie, É. Tourville, John Y Chen, J. Ordóñez-Mena, A. Dirani   +8 more
semanticscholar   +1 more source

Central Serous Chorioretinopathy

Bulgarian Review of Ophthalmology, 2017
Central serous is an atypical form of macular edema with mostly accumulation of fluid under the retina. It contitutes a pure phenotype of retinal pigment epithelium barrier breakdown. Another particularity is the good visual preservation despite important fluid volume increase in the macula.
Alejandra, Daruich, Alexandre, Matet, Francine, Behar-Cohen   +2 more
  +7 more sources